A case with two faces: noncompaction or phospholamban cardiomyopathy?

Cardiovasc Pathol. 2022 Mar-Apr:57:107395. doi: 10.1016/j.carpath.2021.107395. Epub 2021 Nov 6.

Abstract

Noncompaction cardiomyopathy is a well-known clinical entity, whereas phospholamban gene mutation is a relatively recently known mutation with phenotypes as arrhythmogenic cardiomyopathy and dilated cardiomyopathy. We report the case of a 15-year-old girl that presents with rapid progressive heart failure based on a noncompaction cardiomyopathy as confirmed through cardiovascular imaging. As a result of her progressive heart failure 22 months later she received a heart transplant. Genetic testing showed a phospholamban gene mutation. We present cardiovascular images together with macroscopic and microscopic anatomy. This case shows the importance of considering phospholamban gene mutation in a case of severe noncompaction cardiomyopathy.

Keywords: cardiomyopathy; heart transplant; noncompaction; phospholamban.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Calcium-Binding Proteins / genetics
  • Cardiomyopathies* / diagnostic imaging
  • Cardiomyopathies* / genetics
  • Cardiomyopathy, Dilated* / genetics
  • Female
  • Genetic Testing
  • Humans

Substances

  • Calcium-Binding Proteins
  • phospholamban